the end.

early on in the treatment course.

I will say half of the patients, when they present for the first cycle of CRS, the chances of them having some form of a CRS reaction is about 50%.

By the time they come back a week later, maybe about a quarter of the patients might be at risk for CRS.

And really, we've exclusively seen the CRS reaction in the first two infusions.

When patients get beyond those first two infusions, unless there's a major treatment delay, we're not seeing it.

So it's really mostly exclusively those first two infusions.

who doesn't love that? Who wants to be in clinic for six